Intravaginal magnesium sulfate as an alternative to intravenous dexamethasone for labor acceleration: first direct comparison in a bayesian adaptive trial
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
OBJECTIVE: Labor acceleration remains a major challenge in obstetric care. Although intravenous (IV) dexamethasone has been shown to be effective for labor acceleration, its systemic adverse effects limit its use. Intravaginal magnesium sulfate (MgSO4) may offer a potential alternative; however, comparative studies are needed. This study compared the safety and efficacy of these interventions for labor acceleration. METHODS: This Bayesian adaptive, three-arm randomized controlled trial enrolled 150 women in latent labor and assigned them to receive intravaginal MgSO4 (50%; 10 mL), IV dexamethasone (8 mg), or usual care. The primary outcomes were labor duration and change in Bishop score; secondary outcomes included Apgar scores. RESULTS: Both active treatments significantly improved Bishop scores compared with control at 6 hours (3.06 vs. 3.05 points; P
Fields of Study & Subjects
Maternal and Perinatal Health Interventions
Preterm Birth and Chorioamnionitis
Anesthesia and Pain Management
Publication details
- Journal / source
- Obstetrics & Gynecology Science
- Volume
- 69
- Issue
- 3
- Pages
- 172–182
- Publication date
- 30 March 2026
- Language
- EN